Recently, Toda’s group evaluated the expression of PD-L1, IDO1, CD3, CD4, and CD8 in tumor tissues collected by biopsy or surgical resection from 56 OS patients, by comparing primary and metastatic lesions, and samples before neo-adjuvant chemotherapy (NAC) and after NAC [38]. This evidence concerns the gene CD4 and neoplasm.